Document Type

Journal Article

Publication Title

Aging Clinical and Experimental Research

Volume

37

Issue

1

PubMed ID

39838216

Publisher

Springer

School

Centre for Precision Health / School of Science

RAS ID

78179

Funders

Western Australian Future Health Research and Innovation Fund (WANMA/EL2023-24/2) / Edith Cowan University (G1006465)

Comments

Zheng, Y., Guo, Z., Wang, J., Wu, Z., Chen, X., Zhu, Y., ... & Li, X. (2025). Exploring and validating associations between six systemic inflammatory indices and ischemic stroke in a middle-aged and old Chinese population. Aging Clinical and Experimental Research, 37. https://doi.org/10.1007/s40520-024-02912-6

Abstract

Background: Inflammation and maladaptive immune mechanisms have been substantiated as integral components in the critical pathological processes of the injury cascade in ischemic stroke (IS). This study aimed to explore the associations between six systemic inflammatory indices and IS in a Chinese population. Methods: This was a case-control study based on the retrospective review of electronic medical records from two hospitals in Shandong Province, China. Systemic inflammatory indices, including the systemic inflammation response index (SIRI), systemic immune inflammation index (SII), pan-immune-inflammation value (PIV), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR), were calculated. Logistic regression models and classification analyses were employed to evaluate associations and discriminatory abilities. Results: In total, 9392 participants aged 40–83 years old were included in the discovery (3620 pairs of IS-present cases and healthy controls) and validation (1076 pairs of IS-present cases and IS-absent controls with IS mimics) datasets. After adjusting for potential confounding factors, IS was found to be associated with all six systemic indices in the discovery dataset, including SIRI (odd ratio [OR] 8.77, 95% confidence interval [CI] 7.48–10.33), SII (1.03, 1.01–1.04), PIV (1.01, 1.01–1.01), NLR (2.23, 2.08–2.39), PLR (1.01, 1.01–1.01), and LMR (0.77, 0.75–0.78). Notably, only LMR exhibited significant associations with IS in both discovery and validation datasets (0.88, 0.83–0.93), suggesting an independent protective role of this index. SIRI, SII, PIV, NLR, and LMR showed good discriminative ability between IS patients and healthy controls in the discovery dataset (AUCs > 0.70). However, they performed poorly in distinguishing IS patients from IS mimics in the validation dataset (AUCs < 0.60). Conclusion: This study provides valuable insights into the associations between systemic inflammatory indices and IS, offering potential implications for risk stratification. While these inflammatory indices are potential indicators for distinguishing IS from healthy conditions, additional biomarkers may be needed when differentiating IS from other chronic inflammatory conditions in clinical practice.

DOI

10.1007/s40520-024-02912-6

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Included in

Epidemiology Commons

Share

 
COinS